101140 — InBioGen Co Cashflow Statement
0.000.00%
Last trade - 00:00
IndustrialsHighly SpeculativeMicro Cap
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 13,124 | -45,078 | 94,125 | -119,687 | 18,857 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -13,982 | 41,006 | -101,259 | 107,843 | -23,597 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -3,225 | -4,405 | -1,052 | -1,099 | 2,465 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -3,828 | -8,033 | -7,069 | -11,505 | -1,051 |
Capital Expenditures | -416 | -971 | -2,402 | -331 | -331 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -54,626 | -4,895 | -38,035 | -15,594 | 138 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -55,042 | -5,866 | -40,437 | -15,925 | -193 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 66,295 | 14,970 | 61,543 | 13,568 | -1,957 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 7,425 | 1,072 | 14,038 | -13,862 | -3,201 |